Bank Of New York Mellon Corp Brooklyn Immuno Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.48 - $2.03 $32,139 - $135,922	-66,957 Reduced 57.43%	49,635 $26,000
Q1 2022 May 11, 2022	SELL	$1.76 - $4.84 $432 - $1,190	-246 Reduced 0.21%	116,592 $240,000
Q4 2021 Feb 11, 2022	BUY	$4.17 - $9.79 $134,148 - $314,944	32,170 Added 38.0%	116,838 $487,000
Q3 2021 Nov 12, 2021	BUY	$8.86 - $17.05 $114,515 - $220,371	12,925 Added 18.02%	84,668 $787,000
Q2 2021 Aug 11, 2021	BUY	$3.75 - $78.5 $269,036 - $5.63 Million	71,743 New	71,743 $1.29 Million

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.